trial

Prebiotic Treatment in People With Schizophrenia - Pilot Study

NCTId NCT03617783
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 26 (actual)
Sponsored by University of Maryland, Baltimore County
Primary completion 2022-04-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
26 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2019-07-18
Primary completion
2022-04-05
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Prebiotin

Sponsors

University of Maryland, Baltimore CountyLead Sponsor

Sites

1 total
Catonsville, United States

Facts & assertions

4 sourced
Enrollment
26
Phase
PHASE4
Primary Completion Date
2022-04-05
Status
COMPLETED
relationships
The graph out of here
drug
Prebiotin
drug
lead_sponsor
University of Maryland, Baltimore County
company
indication
Schizophrenia
indication
Schizoaffective Disorder
indication
Schizophrenia
indication